These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1163240)

  • 1. Acetylene compounds of potential pharmacological value. XIX. N-(dialkylaminoalkynyl)-substituted succinimides and 2-pyrrolidones as partial cholinergic agonists.
    Svensson U; Dahlbom R
    Acta Pharm Suec; 1975; 12(3):209-14. PubMed ID: 1163240
    [No Abstract]   [Full Text] [Related]  

  • 2. Acetylene compounds of potential pharmacological value. XXI. Further studies on the effect of branching the intermediate chain of N-(t-aminoalkynyl)-substituted succinimides and 2-pyrrolidones.
    Ringdahl B; Svensson U; Dahlbom R
    Acta Pharm Suec; 1975; 12(4):297-304. PubMed ID: 1199731
    [No Abstract]   [Full Text] [Related]  

  • 3. Acetylene compounds of potential pharmacological value. XXIX. Stereoselectivity of N-(1-alkyl-4-pyrrolidino-2-butynyl)-substituted 2-pyrrolidones and succinimides as oxotremorine antagonists.
    Ringdahl B; Dahlbom R
    Acta Pharm Suec; 1979; 16(1):13-20. PubMed ID: 452907
    [No Abstract]   [Full Text] [Related]  

  • 4. Acetylene compounds of potential pharmacological value. 18. N-(t-aminoalkynyl)-substituted 2-pyrrolidones, a new series of potent oxotremorine antagonists.
    Lindgren S; Lindquist A; Lindeke B; Svensson U; Karlén B; Dahlbom R
    Acta Pharm Suec; 1973 Dec; 10(6):435-40. PubMed ID: 4773112
    [No Abstract]   [Full Text] [Related]  

  • 5. Acetylene compounds of potential pharmacological value. XXIII. N-(1-Methyl-5-pyrrolidino-3-pentynyl)-substituted succinimide and 2-pyrrolidone.
    Lindgren S; Svensson U; Dahlbom R
    Acta Pharm Suec; 1975; 12(5-6):503-6. PubMed ID: 1217504
    [No Abstract]   [Full Text] [Related]  

  • 6. Acetylene compounds of potential pharmacological value. XXX. Synthesis and pharmacological properties of N-(4-pyrrolidino-2-pentynyl)-substituted 2-pyrrolidone and succinimide.
    Resul B; Ringdahl B; Dahlbom R
    Acta Pharm Suec; 1979; 16(3):161-5. PubMed ID: 484249
    [No Abstract]   [Full Text] [Related]  

  • 7. Acetylene compounds of potential pharmacological value. XVI. N-(perhydroazepinoalkynyl)- and N-(perhydroazocinoalkynyl)succinimides.
    Lindquist A; Lindgren S; Lindeke B; Karlén B; Dahlbom R; Blair MR
    Acta Pharm Suec; 1972 Apr; 9(2):93-8. PubMed ID: 5030544
    [No Abstract]   [Full Text] [Related]  

  • 8. Stereospecificity of oxotremorine antagonists.
    Dahlbom R; Lindquist A; Lindgren S; Svensson U; Ringdahl B; Blair MR
    Experientia; 1974 Oct; 30(10):1165-7. PubMed ID: 4435124
    [No Abstract]   [Full Text] [Related]  

  • 9. Acetylene compounds of potential pharmacological value. XXII. Base strength and biological activity in oxotremorine antagonists.
    Svensson U; Ringdahl B; Dahlbom R
    Acta Pharm Suec; 1975; 12(5-6):393-400. PubMed ID: 1217491
    [No Abstract]   [Full Text] [Related]  

  • 10. Acetylene compounds of potential pharmacological value. IX. N-(4-dialkylamino-2-butynyl)-substituted carboxylic and sulphonic acid amides.
    Dahlbom R; Karlén B; Lindquist A; George R; Jenden DJ
    Acta Pharm Suec; 1967 Sep; 4(4):247-52. PubMed ID: 6082975
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclopropane analogues to acetylenic oxotremorine antagonists.
    Grundström K; Dahlbom R
    Acta Pharm Suec; 1972 Nov; 9(5):491-8. PubMed ID: 4650125
    [No Abstract]   [Full Text] [Related]  

  • 12. Acetylene compounds of potential pharmacological value. XXV. N-(4-pyrrolidino-2-butynyl)-N-alkylcarboxamides.
    Svensson U; Hacksell U; Dahlbom R
    Acta Pharm Suec; 1978; 15(1):67-70. PubMed ID: 645369
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and pharmacological evaluation of a new class of 2-oxo-8-azaspiro (4,5)decan-1-ones as analogues of the muscarinic agonist RS-86.
    Cignarella G; Villa S; Barlocco D
    Farmaco; 1993 Oct; 48(10):1439-45. PubMed ID: 8117382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Methyl-2-pyrrolidone analogues of oxotremorine as selective muscarinic agonists.
    Ringdahl B
    J Med Chem; 1988 Mar; 31(3):683-8. PubMed ID: 3346881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of 1-(2-oxo-1-pyrrolidino)-4-(2-chloroethyl-methylamino)but-2-yne-HCl (DSO-16), I. Its central cholinomimetic and cholinolytic effects on mice.
    György L; Gellén B; Dóda M; Sterk L
    Acta Physiol Acad Sci Hung; 1971; 40(3):373-9. PubMed ID: 5147960
    [No Abstract]   [Full Text] [Related]  

  • 16. Acetylene compounds of potential pharmacological value. VII. 4-Dialkylamino-2-butynyl ethers.
    Dahlbom R; Karlén B; Lindquist A
    Acta Pharm Suec; 1966 Jun; 3(3):187-96. PubMed ID: 5967304
    [No Abstract]   [Full Text] [Related]  

  • 17. Acetylene compounds of potential pharmacological value. XXVII. Stereoselectivity of oxotremorine antagonists containing a chiral pyrrolidine group.
    Ringdahl B; Dahlbom R
    Acta Pharm Suec; 1978; 15(4):255-63. PubMed ID: 726907
    [No Abstract]   [Full Text] [Related]  

  • 18. Dimethylsulfonium and thiolanium analogues of the muscarinic agent oxotremorine.
    Ringdahl B
    J Med Chem; 1988 Jan; 31(1):164-8. PubMed ID: 3336015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylene compounds of potential pharmacological value. XXXI. Studies on N-(4-tert-amino-2-butynyl) carboxamides as muscarinic agonists.
    Resul B; Ringdahl B; Hacksell U; Svensson U; Dahlbom R
    Acta Pharm Suec; 1979; 16(4):225-32. PubMed ID: 543393
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anticholinergic effects depending on the chemical constitution of a series of tertiary and quaternary propylamine derivatives].
    Ehrhart G; Härtfelder G; Schmitt K
    Arzneimittelforschung; 1970 Aug; 20(8):1094-6. PubMed ID: 5536510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.